This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

May 2022

May 2022

Industry leaders & service providers uncover leading strategies for expediting R&D and improving CMC efficiency

Delivered as a Complimentary Webinar Series

Why Attend TIDES Digital Week?

Time and Cost Efficient

You will save valuable time and money because there is no need to travel and no registration fee. During this unexpected COVID-19 situation, take advantage of being able to gain some knowledge & training in 2021 H1 from the convenience of your home.

Focused and Timely Learning

You will receive the latest "hot" and timely data from a leading authority. Our webinars feature live scientific technology demonstrations presented by leading scientists and engineers working across the entire spectrum of oligonucleotide and peptide development and production. 


You can participate in a webinar from a location of your choosing – your home, your office, or a client/customer location. We also offer the webinar sessions on-demand for you to watch on your own time, whether you couldn't make a session or you want to rewatch it.


Join us at one of our upcoming virtual TIDES training courses.

Informa training courses provide in-depth teaching and discussion about highly technical and scientific topics relevant to the TIDES community that can not be covered at a conference. With 6+ hours of dedicated instruction in a classroom-like (teacher/student) environment, a training course will offer you interactive opportunities with the instructor and fellow attendees so you can get your most pressing questions answered in a much more individualized setting.

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides from Early Development to Registration

September 14-16 (Virtual)
Learn how to develop an evolving control strategy for your drug substance — from early development to registration. The course will also discuss the issues and risks that can be developed, addressed and mitigated during development

Introduction to Oligonucleotide Conjugate Strategies

June 8-10 and October 26-28 (Both Virtual)
Understand how to best design oligonucleotide conjugates — from simple starting building blocks to the full oligonucleotide conjugate. With full consideration of the biological behavior of both the finished molecule and all of its individual components.